Posted by Michael Wonder on 28 Nov 2022
Joint statement: NICE and SMC/HIS collaboration
25 November 2022 - NICE and SMC/HIS collaboration on the health technology appraisal of tixagevimab–cilgavimab (Evusheld) for preventing COVID-19.
Throughout the COVID-19 pandemic NICE and Healthcare Improvement Scotland (HIS) have collaborated with other partners to ensure rapid access to medicines for COVID-19 through the Research to access pathway for investigational drugs for COVID-19 (RAPID C-19) initiative.
